ScholarIQanswers from OpenAlex
Incyte
FunderResearch funding and supported work
Incyte is a funder indexed in ScholarIQ from OpenAlex.
What is known about Incyte?
ScholarIQrecord summary
American pharmaceutical company
How many works does Incyte have?
ScholarIQindexed works
Incyte has 5,877 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for Incyte?
ScholarIQopenalex
The OpenAlex for Incyte is on the source record.
What are the most-cited papers on Incyte?
ScholarIQmost cited works
<i>EGFR</i> -Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes
Nicolas Marcoux, Scott Gettinger, Grainne M. O’Kane, Kathryn C. Arbour, Joel W. Neal, Hatim Husain, Tracey L. Evans, Julie R. Brahmer, Alona Muzikansky, Philip Bonomi, Salvatore Del Prete, Anna Wurtz, Anna F. Farago, Dora Dias‐Santagata, Mari Mino–Kenudson, Karen L. Reckamp, Helena A. Yu, Heather A. Wakelee, Frances A. Shepherd, Zofia Piotrowska, Lecia V. Sequist
Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA/ENGOT-OV26/GOG-3012 trial
B.J. Monk, Maria Pilar Barretina-Ginesta, Bhavana Pothuri, Ignace Vergote, Whitney A. Spannuth Graybill, Mansoor Raza Mirza, C. C. McCormick, Domenica Lorusso, Richard G. Moore, Gilles Freyer, Roisin E. O’Cearbhaill, Florian Heitz, David M. O’Malley, Andrés Redondo, Mark S. Shahin, Christof Vulsteke, William H. Bradley, Charlotte Aaquist Haslund, Dana M. Chase, Carmela Pisano, L.L. Holman, M.J. Rubio Pérez, Paul DiSilvestro, Lydia Gaba, Thomas J. Herzog, Ilan Bruchim, Natalie Compton, L. Shtessel, Izabela A. Malinowska, Antonio González-Martı́n
Costs and Treatment Patterns Among Patients with Atopic Dermatitis Using Advanced Therapies in the United States: Analysis of a Retrospective Claims Database
Lawrence F. Eichenfield, Marco DiBonaventura, Jason Xenakis, Marie‐Hélène Lafeuille, Mei Sheng Duh, Iman Fakih, Mark Levenberg, Joseph C. Cappelleri, Vanja Sikirica
Small cell transformation in EGFR-mutated non-small cell lung cancer: DLL3 expression and efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors combined with chemotherapy
Felix Carl Saalfeld, Johanna Möller, Petros Christopoulos, Carina Wenzel, Anna Rasokat, Xuefu Wang, Ioannis Vathiotis, David König, Oliver Illini, Christian Grohé, Marcel Wiesweg, Claas Wesseler, Christoph Schubart, Natalie Pelusi, Gernot Rohde, Tobias R. Overbeck, Jutta Kirfel, Jürgen Alt, Diego Kauffmann‐Guerrero, Frank Griesinger, Jonas Kulhavy, Michael Allgäuer, Anna Klimová, Maret Schütz, Daniela E. Aust, Maximilian J. Hochmair, Sacha I. Rothschild, Konstantinos N. Syrigos, Rajwanth Veluswamy, Sebastian Michels, Albrecht Stenzinger, Korinna Jöhrens, Martin Wermke
Long-Term Effectiveness of Dupilumab in Patients with Atopic Dermatitis: Results up to 3 Years from the RELIEVE-AD Study
Alexa B. Kimball, Dimittri Delevry, Min Yang, Chien‐Chia Chuang, Zhixiao Wang, Gaëlle Bégo-Le-Bagousse, Bruno Martins, Eric Q. Wu, Brad Shumel, Jessie Wang, Debra Sierka, Jingdong Chao, Bruce Strober